A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Elevation Oncology
Shanghai PerHum Therapeutics Co., Ltd.
NantCell, Inc.
pharmaand GmbH
MacroGenics
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota
Stanford University
National Cancer Institute (NCI)